A message from Robert McMaster and Teresa Tsang.
We are delighted to announce the appointment of Dr. Peter Black as Director of the Vancouver Prostate Centre (VPC), effective to June 30, 2029.
Dr. Black is a professor and vice chair in the Department of Urologic Sciences, a senior research scientist and the Associate Director of Clinical Research at VPC. As a surgeon-scientist, his clinical subspecialty focuses on the treatment of urologic cancers, with a particular emphasis on bladder and prostate cancer. In addition to his clinical work, Dr. Black leads a translational research program that focuses on bladder cancer responses and resistance to chemotherapy, as well as developing novel targeted therapies for bladder cancer. His contributions have earned him numerous accolades, including Best Clinical Paper Published in Literature by the European Association of Urology and the UBC Faculty of Medicine Distinguished Achievement Award for Excellence in Clinical or Applied Research.
In addition, Dr. Black serves as General Secretary of the International Bladder Cancer Network, and previously held a position on the Board of Directors for the Société Internationale d’Urologie, where he was the founding editor-in-chief of the society’s journal.
As Director of VPC, Dr. Black will play a pivotal role in shaping the centre’s research strategy. His vision is to foster a collaborative environment that promotes the highest standards of scientific integrity and excellence. He will focus on developing strategic partnerships that support the work of investigators and scientists, while further integrating research and mentorship within the centre. Additionally, Dr. Black is committed to further advancing VPC’s high impact cutting-edge research and championing a culture of equity, diversity and inclusion in all of its research endeavours.
Dr. Black succeeds Dr. Martin Gleave, whose outstanding leadership from 2006 to 2024 positioned the VPC as a global leader in prostate cancer research and treatment. Under Dr. Gleave’s stewardship, the centre has reached remarkable milestones in enhancing patient care and research. We extend our heartfelt gratitude to Dr. Gleave for his dedication, vision and tireless efforts.
Please join us in expressing our sincere thanks to Dr. Gleave and in congratulating Dr. Black as he assumes this role.
